Abion Inc.

Abion Inc. is a pioneering biotechnology research company committed to advancing precision oncology and providing innovative solutions for lung cancer and infectious diseases. Established in 2007, Abion Inc. stands at the forefront of Korean biopharma, dedicated to developing cutting-edge therapies and improving patient outcomes. With a robust pipeline of drug candidates in preclinical and clinical stages, Abion Inc. is actively engaged in research and clinical partnerships to accelerate the development and commercialization of its novel treatments.

Located at 242 Digital-ro, Guro-gu, Seoul, KR, Abion Inc. is driven by a mission to transform healthcare through scientific excellence and innovative approaches. The company specializes in precision oncology and companion diagnostic-based medicines, ensuring that patients receive the most targeted and effective treatments available. Abion Inc. is committed to collaborating with leading researchers and healthcare professionals to address unmet medical needs and improve the lives of patients worldwide.

Abion Inc. continues to expand its research capabilities and clinical programs, solidifying its position as a leader in the biotechnology industry. The company's dedication to innovation and patient-centric care makes it a valuable partner in the fight against lung cancer and infectious diseases. We invite the management team at Abion Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and attract new collaborations.